XML 131 R50.htm IDEA: XBRL DOCUMENT
v3.26.1

Investment in associates (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2026
IfrsStatementLineItems [Line Items] |
Schedule of investment in associates | Schedule of investment in associates
|  | 2026 |  |  | 2025 |
|  | USD |  |  | USD |
Unquoted shares - at cost |  |  |  |  |  |  |  |
As at April 1 |  |  | 1,493,850 |  |  |  | 1,493,850 |
Unquoted shares - at cost beginning |  |  | 1,493,850 |  |  |  | 1,493,850 |
Disposal during the financial year |  |  | (677 | ) |  |  | - |
Reclassification to Other Investment during the financial year (Note 8) |  |  | (1,492,955 | ) |  |  | - |
As at March 31 |  |  | 218 |  |  |  | 1,493,850 |
Unquoted shares- at cost end |  |  | 218 |  |  |  | 1,493,850 |
Less: Accumulated impairment loss |  |  |  |  |  |  |  |
As at April 1 |  |  | (257 | ) |  |  | (257 | )
Accumulated impairment loss beginning |  |  | (257 | ) |  |  | (257 | )
Reversal of impairment during the financial year |  |  | 263 |  |  |  | - |
Exchange difference |  |  | (6 | ) |  |  | - |
As at March 31 |  |  | - |  |  |  | (257 | )
Accumulated impairment loss ending |  |  | - |  |  |  | (257 | )
Unquoted shares- at cost, net |  |  | 218 |  |  |  | 1,493,593 |
Share of post-acquisition reserve |  |  |  |  |  |  |  |
As at April 1 |  |  | 3,151 |  |  |  | 13,911 |
Share of post-acquisition reserve beginning |  |  | 3,151 |  |  |  | 13,911 |
Share profit((loss) during the financial year |  |  | 14,449 |  |  |  | (10,760 | )
As at March 31 |  |  | 17,600 |  |  |  | 3,151 |
Share of post-acquisition reserve ending |  |  | 17,600 |  |  |  | 3,151 |
Share of post- acquisition reserve, net |  |  | 17,818 |  |  |  | 1,496,744 |
Exchange differences |  |  | 788 |  |  |  | 99,432 |
Investment in associates |  |  | 18,606 |  |  |  | 1,596,176 |
Schedule of details of associates | The details of associates are as follows: Schedule of details of associates
|  | Place of business/ Country of |  | Effective equity |  |  |
Name of Company |  | incorporation |  | interest |  |  | Principal activities
|  |  |  | 2026 |  |  | 2025 |  |  |
|  |  |  | % |  |  | % |  |  |
Vax Biotech Sdn. Bhd. (“Vax Biotech”) |  | Malaysia |  |  | - |  |  |  | 30 | % |  | Manufacture of medicaments
Alps Globemedics Sdn. Bhd. (“Alps Globemedics”) |  | Malaysia |  |  | 30 | % |  |  | 30 | % |  | Marketing of health and beauty product and services
Cilo Cybin Holdings Limited (“Cilo Cybin”) |  | South Africa |  |  | - |  |  |  | 40.5 | % |  | Investment in biotech, biohacking and pharmaceutical businesses
Alps Globemedics Sdn Bhd [member] |
IfrsStatementLineItems [Line Items] |
Schedule of financial information represents the amount in the financial statements | Schedule of financial information represents the amount in the financial statements
Alps Globemedic Sdn Bhd |  | 2026 |  |  | 2025 |
|  | USD |  |  | USD |
Statement of financial position |  |  |  |  |  |  |  |
Non-current assets |  |  | 3,274 |  |  |  | 3,529 |
Current assets |  |  | 190,038 |  |  |  | 36,502 |
Total assets |  |  | 193,312 |  |  |  | 40,031 |
Current liabilities |  |  | (131,329 | ) |  |  | (16,483 | )
Total liabilities |  |  | (131,329 | ) |  |  | (16,483 | )
Net assets of the associate |  |  | 61,983 |  |  |  | 23,548 |
Statement of comprehensive income |  |  |  |  |  |  |  |
Revenue for the financial year |  |  | 268,615 |  |  |  | 187,465 |
Profit for the financial year |  |  | 34,606 |  |  |  | 7,375 |
Share of profit of the associate |  |  | 10,382 |  |  |  | 2,213 |
Schedule of financial information to the carrying amount of interest | Schedule of financial information to the carrying amount of interest
|  | 2025 |  |  | 2025 |
|  | USD |  |  | USD |
Proportion of net assets of the associate |  |  | 18,595 |  |  |  | 7,421 |
Exchange differences |  |  | 11 |  |  |  | (357 | )
Carrying amount of the Group’s interest in associate |  |  | 18,606 |  |  |  | 7,064 |

X
- Definition Disclosure of detailed information about financial information to carrying amount of interest explanatory. + References No definition available. + Details
Name: | ALPS_DisclosureOfDetailedInformationAboutFinancialInformationToCarryingAmountOfInterestExplanatory
Namespace Prefix: | ALPS_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of investments in associates explanatory. + References No definition available. + Details
Name: | ALPS_DisclosureOfInvestmentsInAssociatesExplanatory
Namespace Prefix: | ALPS_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ALPS_IfrsStatementLineItems
Namespace Prefix: | ALPS_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of detailed information about financial instruments. [Refer: Classes of financial instruments [domain]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2025-01-01 -Paragraph 31 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2025-01-01 -Paragraph 7 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2025-01-01 -Paragraph 35K -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35K&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 43 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard -URIDate 2025-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 43 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of associates. [Refer: Total for all associates [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 17 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2025-01-01 -Paragraph 16 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2025-01-01 -Paragraph B4 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 75 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_c&doctype=Standard -URIDate 2025-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 75 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_c&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=ALPS_AlpsGlobemedicsSdnBhdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |